Torrent Pharma Slapped Rs 60.28 Lakh NPPA Notice for Alleged Overcharging
Written By : Parthika Patel
Published On 2025-10-05 06:45 GMT | Update On 2025-10-05 06:45 GMT
Advertisement
New Delhi: Torrent Pharmaceuticals Limited has announced that it has received a demand notice from the National Pharmaceutical Pricing Authority (NPPA) imposing a penalty of Rs 60.28 lakh under the provisions of the Drug Price Control Order (DPCO) 2013 for alleged overcharging on two of its drug products.
In a regulatory filing dated 30th September 2025, the company stated that the demand notice, dated 24th September 2025, was issued by NPPA’s office in New Delhi and received by Torrent on 29th September 2025. The notice was issued under Para 15 of the DPCO 2013, which authorizes the authority to recover overcharged amounts from pharmaceutical manufacturers found selling scheduled drugs above government-fixed ceiling prices.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.